Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Pandey

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Oncology|December 3, 2025
Optimizing Natural Killer Cellular Therapy in Acute Myeloid LeukemiaBinsah George, Manu Pandey, Jacob Herstein, et al.
Oncoimmunology|August 16, 2019
Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitorsAhmad Hanif, Manu Pandey, Sumera Khan, et al.
British Journal of Clinical Pharmacology|April 24, 2020
Mechanism-based treatment of cancer with immune checkpoint inhibitor therapiesYara Abdou, Manu Pandey, Maithreyi Sarma, et al.
Immunotherapy|February 18, 2020
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitorsShipra Gandhi, Manu Pandey, Nischala Ammannagari, et al.
Leukemia Research|October 18, 2025
The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysisYuanli Lei, Zhiting Tang, Jessica A Reese, et al.
Cancer Medicine|December 11, 2023
Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survivalOlivia Davis, Derek Truong, Silas Day, et al.
Cellular Immunology|January 23, 2021
Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing miceCameron MacDonald, Samuel Ministero, Manu Pandey, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2023
Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell LymphomaKira MacDougall, Silas Day, Spencer Hall, et al.
The American Journal of Cardiology|May 5, 2026
Comparative Risk of Adverse Cardiovascular Outcomes with Zanubrutinib vs Ibrutinib in B-Cell Malignancies: A Large Real-World Propensity-Matched AnalysisUsama Qamar, Zeeshan Imtiaz, Muhammad Hassan Jan, et al.
Transplantation and Cellular Therapy|September 29, 2025
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United StatesMaria A Pereda Ginocchio, Kristie N Ramos, Manuel R Espinoza-Gutarra, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Oncology|December 3, 2025
Optimizing Natural Killer Cellular Therapy in Acute Myeloid LeukemiaBinsah George, Manu Pandey, Jacob Herstein, et al.
Oncoimmunology|August 16, 2019
Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitorsAhmad Hanif, Manu Pandey, Sumera Khan, et al.
British Journal of Clinical Pharmacology|April 24, 2020
Mechanism-based treatment of cancer with immune checkpoint inhibitor therapiesYara Abdou, Manu Pandey, Maithreyi Sarma, et al.
Immunotherapy|February 18, 2020
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitorsShipra Gandhi, Manu Pandey, Nischala Ammannagari, et al.
Leukemia Research|October 18, 2025
The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysisYuanli Lei, Zhiting Tang, Jessica A Reese, et al.
Cancer Medicine|December 11, 2023
Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survivalOlivia Davis, Derek Truong, Silas Day, et al.
Cellular Immunology|January 23, 2021
Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing miceCameron MacDonald, Samuel Ministero, Manu Pandey, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2023
Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell LymphomaKira MacDougall, Silas Day, Spencer Hall, et al.
The American Journal of Cardiology|May 5, 2026
Comparative Risk of Adverse Cardiovascular Outcomes with Zanubrutinib vs Ibrutinib in B-Cell Malignancies: A Large Real-World Propensity-Matched AnalysisUsama Qamar, Zeeshan Imtiaz, Muhammad Hassan Jan, et al.
Transplantation and Cellular Therapy|September 29, 2025
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United StatesMaria A Pereda Ginocchio, Kristie N Ramos, Manuel R Espinoza-Gutarra, et al.
Pageof 2